We are live on ! Find out more
SOW

State of Wyoming Portfolio holdings

AUM $989M
1-Year Est. Return 52.24%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+52.24%
3 Year Est. Return
+130.83%
5 Year Est. Return
+163.43%
10 Year Est. Return
–
AUM
$159M
AUM Growth
+$97.9M
Cap. Flow
+$90.2M
Cap. Flow %
56.8%
Top 10 Hldgs %
17.52%
Holding
1,254
New
685
Increased
418
Reduced
86
Closed
59

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.69M
2
AAPL icon
Apple
AAPL
+$2.54M
3
META icon
Meta Platforms (Facebook)
META
+$1.97M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.17M
5
HLF icon
Herbalife
HLF
+$1.07M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$12.8M
2
CP icon
Canadian Pacific Kansas City
CP
+$231K
3
XOM icon
ExxonMobil
XOM
+$213K
4
ABBV icon
AbbVie
ABBV
+$184K
5
CMCSA icon
Comcast
CMCSA
+$129K

Sector Composition

Rank Sector Weight
1 Technology 25%
2 Healthcare 16.06%
3 Consumer Discretionary 14.48%
4 Financials 12.2%
5 Communication Services 11.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAM icon
1076
Pampa Energía
PAM
$4.43B
$5K ﹤0.01%
+356
New +$5.38K
PTGX icon
1077
Protagonist Therapeutics
PTGX
$9.71B
$5K ﹤0.01%
121
+64
+112% +$2.11K
UL icon
1078
Unilever
UL
$135B
$5K ﹤0.01%
78
+23
+42% +$1.53K
HZNP
1079
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5K ﹤0.01%
51
+27
+113% +$2.48K
ABEV icon
1080
Ambev
ABEV
$45.4B
$4K ﹤0.01%
1,298
+430
+50% +$1.4K
ADAP
1081
DELISTED
Adaptimmune Therapeutics
ADAP
$4K ﹤0.01%
+825
New +$4K
ADP icon
1082
Automatic Data Processing
ADP
$109B
$4K ﹤0.01%
19
-370
-95% -$71.9K
ASIX icon
1083
AdvanSix
ASIX
$438M
$4K ﹤0.01%
+140
New +$4.2K
AXSM icon
1084
Axsome Therapeutics
AXSM
$11.4B
$4K ﹤0.01%
53
+22
+71% +$1.32K
DDD icon
1085
3D Systems Corp
DDD
$611M
$4K ﹤0.01%
+108
New +$2.85K
IMAX icon
1086
IMAX
IMAX
$2.81B
$4K ﹤0.01%
+186
New +$4.01K
IWF icon
1087
iShares Russell 1000 Growth ETF
IWF
$127B
$4K ﹤0.01%
56
+44
+367% +$2.84K
MRUS
1088
DELISTED
Merus
MRUS
$4K ﹤0.01%
+171
New +$3.78K
RARE icon
1089
Ultragenyx Pharmaceutical
RARE
$2.64B
$4K ﹤0.01%
38
+20
+111% +$2.08K
ATNX
1090
DELISTED
Athenex, Inc. Common Stock
ATNX
$4K ﹤0.01%
+43
New +$3.91K
FINM
1091
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$4K ﹤0.01%
+424
New +$4.12K
ALGS icon
1092
Aligos Therapeutics
ALGS
$47.8M
$3K ﹤0.01%
5
+2
+67% +$1.27K
BCAB icon
1093
BioAtla
BCAB
$5.76M
$3K ﹤0.01%
1
– –
DVAX
1094
DELISTED
Dynavax Technologies
DVAX
$3K ﹤0.01%
270
+123
+84% +$1.12K
INO icon
1095
Inovio Pharmaceuticals
INO
$76.1M
$3K ﹤0.01%
29
+19
+190% +$1.82K
KNSA icon
1096
Kiniksa Pharmaceuticals
KNSA
$5.97B
$3K ﹤0.01%
+235
New +$3.57K
LCID icon
1097
Lucid Motors
LCID
$2.6B
$3K ﹤0.01%
+10
New +$2.19K
NVAX icon
1098
Novavax
NVAX
$1.3B
$3K ﹤0.01%
13
+6
+86% +$1.1K
NWS icon
1099
News Corp Class B
NWS
$17.6B
$3K ﹤0.01%
106
-73
-41% -$1.8K
ORGN
1100
DELISTED
Origin Materials
ORGN
$3K ﹤0.01%
+13
New +$3.87K
42 43
44
45 46

Similar funds

LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
PCM
Polymer Capital Management New York $988M AUM 56.33% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
SMM
Stadion Money Management Watkinsville, Georgia $994M AUM 15.96% 1-Year Est. Return
SWA
Strategies Wealth Advisors Grand Rapids, Michigan $995M AUM 19.35% 1-Year Est. Return
GCM
Gladstone Capital Management London, United Kingdom $996M AUM 50.16% 1-Year Est. Return
N
Numerai San Francisco, California $997M AUM 15.84% 1-Year Est. Return

State of Wyoming's Q2 2021 Portfolio in Review

As of Q2 2021, State of Wyoming held 1,254 positions worth $159M, up 161% from $61M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

State of Wyoming deployed $90.2M of net new capital in Q2 2021, opening 685 new positions and adding to 418 existing holdings. Its largest new stake was Herbalife: 21,542 shares worth $1.14M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $12.8M trimmed.

  • State of Wyoming's largest Q2 2021 buy was Herbalife: 21,542 shares worth $1.14M.
  • State of Wyoming added most to Microsoft in Q2 2021, an estimated $3.69M increase.
  • State of Wyoming's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $12.8M.
  • State of Wyoming fully exited AbbVie in Q2 2021, selling an estimated $184K.
  • State of Wyoming's ten largest holdings make up 18% of its $159M portfolio in Q2 2021.
  • State of Wyoming opened 685 new positions and closed 59 in Q2 2021.
  • State of Wyoming's portfolio value rose 161% quarter-over-quarter to $159M.

Based on State of Wyoming's 13F filing for Q2 2021, filed 11 Feb 2022.